Liver Transplant Unit, Austin Hospital, Heidelberg, Victoria, Australia.
Department of Medicine, University of Melbourne, Heidelberg, Victoria, Australia.
Liver Transpl. 2021 Jul;27(7):1007-1018. doi: 10.1002/lt.26025.
Coronary artery disease (CAD) confers increased perioperative risk in patients undergoing liver transplantation (LT). Although routine screening for CAD is recommended, there are limited data on the effectiveness of screening strategies. We evaluated the safety and efficacy of a 3-tiered cardiac risk-assessment protocol that stratifies patients based on age and traditional cardiac risk factors. We peformed a single-center, prospective, observational study of consecutive adult patients undergoing LT assessment (2010-2017). Patients were stratified into low-risk (LR), intermediate-risk (IR), or high-risk (HR) cardiac groups and received standardized investigations with selective use of transthoracic echocardiography (TTE), dobutamine stress echocardiography (DSE), computed tomography coronary angiography (CTCA), and coronary angiography (CA). Primary outcomes were cardiac events (CEs) and cardiovascular death up to 30 days after LT. Overall, 569 patients were included, with 76 patients identified as LR, 256 as IR, and 237 as HR. Cardiac risk factors included diabetes mellitus (26.0%), smoking history (47.3%), hypertension (17.8%), hypercholesterolemia (7.2%), family (17.0%) or prior history of heart disease (6.0%), and obesity (27.6%). Of the patients, 42.0% had ≥2 risk factors. Overall compliance with the protocol was 90.3%. Abnormal findings on TTE, DSE, and CTCA were documented in 3, 23, and 44 patients, respectively, and 12 patients were not listed for transplantation following cardiac assessment (1 LR, 2 IR, and 9 HR). Moderate or severe CAD was identified in 25.4% of HR patients on CTCA following a normal DSE. CEs were recorded in 7 patients (1.2%), with 2 cardiovascular deaths (0.4%). Cardiac risk stratification based on traditional cardiac risk factors with the selective use of DSE, CTCA, and CA is a safe and feasible approach that results in a low perioperative cardiac event rate.
冠状动脉疾病(CAD)会增加接受肝移植(LT)的患者围手术期的风险。虽然建议对 CAD 进行常规筛查,但有关筛查策略的有效性数据有限。我们评估了一种基于年龄和传统心脏危险因素分层患者的三级心脏风险评估方案的安全性和有效性。我们进行了一项单中心前瞻性观察性研究,连续评估了 2010 年至 2017 年期间接受 LT 评估的成年患者。患者被分为低危(LR)、中危(IR)或高危(HR)心脏组,并接受标准的检查,选择性使用经胸超声心动图(TTE)、多巴酚丁胺负荷超声心动图(DSE)、计算机断层冠状动脉造影(CTCA)和冠状动脉造影(CA)。主要结局是 LT 后 30 天内的心脏事件(CEs)和心血管死亡。总体而言,共纳入 569 例患者,其中 76 例为 LR,256 例为 IR,237 例为 HR。心脏危险因素包括糖尿病(26.0%)、吸烟史(47.3%)、高血压(17.8%)、高胆固醇血症(7.2%)、家族史(17.0%)或既往心脏病史(6.0%)和肥胖症(27.6%)。其中 42.0%的患者有≥2 个危险因素。总体上,该方案的依从率为 90.3%。TTE、DSE 和 CTCA 的异常发现分别在 3、23 和 44 例患者中记录,12 例患者经心脏评估后未被列入移植名单(1 例 LR、2 例 IR 和 9 例 HR)。在 DSE 正常的情况下,根据传统心脏危险因素对 HR 患者进行 CTCA 检查,发现中度或重度 CAD 占 25.4%。7 例患者(1.2%)记录到心脏事件,2 例心血管死亡(0.4%)。基于传统心脏危险因素,选择性使用 DSE、CTCA 和 CA 进行心脏风险分层是一种安全可行的方法,可导致围手术期心脏事件发生率较低。